BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8140136)

  • 1. Free radical scavenger prodrugs--potentially potent brain penetrating agents.
    Benes L; Pronayová N
    Pharmazie; 1994 Jan; 49(1):69-70. PubMed ID: 8140136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on synthesis and properties of N-benzoyl-THA targeting for brain].
    Gong T; Zhang Z; Liu L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Feb; 21(1):21-4. PubMed ID: 15022455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of p-glycoprotein inhibitors on the blood-brain barrier permeation of cyclic prodrugs of an opioid peptide (DADLE).
    Ouyang H; Andersen TE; Chen W; Nofsinger R; Steffansen B; Borchardt RT
    J Pharm Sci; 2009 Jun; 98(6):2227-36. PubMed ID: 18855917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On differences in the penetration of the hemato-encephalic barrier by cholinolytic agents].
    Pechenkin VA
    Biull Eksp Biol Med; 1966 May; 61(5):72-4. PubMed ID: 6002397
    [No Abstract]   [Full Text] [Related]  

  • 5. Channa punctata brain metallothionein is a potent scavenger of superoxide radicals and prevents hydroxyl radical-induced in vitro DNA damage.
    Atif F; Kaur M; Ansari RA; Raisuddin S
    J Biochem Mol Toxicol; 2008; 22(3):202-8. PubMed ID: 18561335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model.
    Chen W; Yang JZ; Andersen R; Nielsen LH; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):849-57. PubMed ID: 12388672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat.
    Nagel S; Genius J; Heiland S; Horstmann S; Gardner H; Wagner S
    Brain Res; 2007 Feb; 1132(1):210-7. PubMed ID: 17184751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
    Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
    Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
    Greene DL; Hau VS; Abbruscato TJ; Bartosz H; Misicka A; Lipkowski AW; Hom S; Gillespie TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.
    Hall ED; Braughler JM; Yonkers PA; Smith SL; Linseman KL; Means ED; Scherch HM; Von Voigtlander PF; Lahti RA; Jacobsen EJ
    J Pharmacol Exp Ther; 1991 Aug; 258(2):688-94. PubMed ID: 1865365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
    Sheha M
    Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
    Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs.
    Giorgioni G; Claudi F; Ruggieri S; Ricciutelli M; Palmieri GF; Di Stefano A; Sozio P; Cerasa LS; Chiavaroli A; Ferrante C; Orlando G; Glennon RA
    Bioorg Med Chem; 2010 Mar; 18(5):1834-43. PubMed ID: 20153654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
    Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycyclic cage structures as carrier molecules for neuroprotective non-steroidal anti-inflammatory drugs.
    Prins LH; du Preez JL; van Dyk S; Malan SF
    Eur J Med Chem; 2009 Jun; 44(6):2577-82. PubMed ID: 19233517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
    Gynther M; Ropponen J; Laine K; Leppänen J; Haapakoski P; Peura L; Järvinen T; Rautio J
    J Med Chem; 2009 May; 52(10):3348-53. PubMed ID: 19402664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marchantin H as a natural antioxidant and free radical scavenger.
    Hsiao G; Teng CM; Wu CL; Ko FN
    Arch Biochem Biophys; 1996 Oct; 334(1):18-26. PubMed ID: 8837734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
    Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
    Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between free radicals and excitatory amino acids in the blood-brain barrier disruption after iron injury in the rat.
    Zuccarello M; Anderson DK
    J Neurotrauma; 1993; 10(4):397-403. PubMed ID: 8145263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen.
    Fan W; Wu Y; Li XK; Yao N; Li X; Yu YG; Hai L
    Eur J Med Chem; 2011 Sep; 46(9):3651-61. PubMed ID: 21641697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.